The Enterprise Value as of December 2025 (TTM) for TuHURA Biosciences, Inc. (HURA) is 92.82M

According to TuHURA Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 92.82M. This represents a change of 40.68% compared to the average of 65.98M of the last 4 quarters.

TuHURA Biosciences, Inc. (HURA) Historical Enterprise Value (quarterly & annually)

How has HURA Enterprise Value performed in the past?

The mean historical Enterprise Value of TuHURA Biosciences, Inc. over the last ten years is 1.90M. The current 92.82M Enterprise Value has changed 487.70% with respect to the historical average. Over the past ten years (40 quarters), HURA's Enterprise Value was at its highest in in the December 2024 quarter at 160.65M. The Enterprise Value was at its lowest in in the September 2020 quarter at -21476820.00.

TuHURA Biosciences, Inc. (HURA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TuHURA Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TuHURA Biosciences, Inc. (HURA) Average Enterprise Value

How has HURA Enterprise Value performed in the past?

The current Enterprise Value of TuHURA Biosciences, Inc. (HURA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TuHURA Biosciences, Inc. (HURA) Enterprise Value vs. Peers

How is HURA’s Enterprise Value compared to its peers?

TuHURA Biosciences, Inc.’s Enterprise Value is greater than Seer, Inc. (86.40M), greater than VistaGen Therapeutics, Inc. (78.69M), less than Opus Genetics, Inc. (121.30M), less than Agenus Inc. (181.50M), less than Cognition Therapeutics, Inc. (119.19M), less than Seres Therapeutics, Inc. (194.69M), greater than Spero Therapeutics, Inc. (83.18M), greater than Acumen Pharmaceuticals, Inc. (76.70M), greater than Tevogen Bio Holdings Inc. (85.88M), less than Inovio Pharmaceuticals, Inc. (94.56M),

Build a custom stock screener for TuHURA Biosciences, Inc. (HURA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TuHURA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TuHURA Biosciences, Inc. (HURA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TuHURA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.